Arch Therapeutics, Inc.Arch Therapeutics, Inc.Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

Inga transaktioner
Se i superdiagram

ARTH fundamenta

Arch Therapeutics, Inc. earnings per share and revenue

Estimated earnings per share for the next quarter are 74.00 USD, and revenue is expected to reach 110.67 M USD. Also watch annual changes over time to get a bigger picture of ARTH earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
Utdelning per andel
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning
Omsättning
‪0.00‬
Rapporterad
Uppskattning
Rapporterad
Uppskattning
Överraskning